NCT02972463View on ClinicalTrials.gov

The Influence of IgY Max on Inflammatory Markers and the Gut Microbiome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 13, 2017

Primary Completion Date

January 12, 2018

Study Completion Date

January 12, 2018

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Immunoglobulin Y

OTHER

Placebo

Trial Locations (1)

N1G 0B4

Nutrasource, Guelph

All Listed Sponsors
collaborator

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

lead

Igy Nutrition, LLC

INDUSTRY

NCT02972463 - The Influence of IgY Max on Inflammatory Markers and the Gut Microbiome | Biotech Hunter | Biotech Hunter